BeStock  

Fresenius Medical Care FMS

US equityMarket cap rank #1364Medical Care Facilities
$20.44 +$0.31 (+1.54%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $20.44 0.00%
Open$20.49
Prev close$20.13
Day range$20.38 – $20.72
Volume1.34M
Market cap$10.61B
P/E (TTM)12.5
Dividend yield4.14%

Fundamentals

Latest reported quarter: Q3, ended Sep 2026 · reported in EUR

Revenue€4.94B+1.1% YoY
Operating profit€473.05M-6.0% YoY
Net profit€224.80M-31.3% YoY
Diluted EPS€0.31-35.1% YoY
Free cash flow€559.59M+1.9% YoY
Operating cash flow€797.56M

Revenue, last 8 quarters

€5.1BDec '24€4.9BMar '25€4.8BJun '25€4.9BSep '25€5.1BDec '25€4.6BMar '26€4.9BJun '26€4.9BSep '26

Net profit, last 8 quarters

€118.1MDec '24€189.6MMar '25€272.3MJun '25€327.3MSep '25€402.0MDec '25€164.8MMar '26€293.2MJun '26€224.8MSep '26

Diluted EPS by quarter

0.12Dec '240.26Mar '250.39Jun '250.47Sep '250.57Dec '250.22Mar '260.41Jun '260.31Sep '26

Free cash flow by quarter

€591.0MDec '24€17.1MMar '25€620.5MJun '25€549.3MSep '25€578.7MDec '25€36.8MMar '26€619.9MJun '26€559.6MSep '26

Annual revenue

€17.9BFY20€17.6BFY21€19.4BFY22€19.5BFY23€19.3BFY24€19.6BFY25

Profitability & balance sheet

Gross margin26.5%
Operating margin10.0%
Net margin4.2%
Return on equity6.4%
Return on assets2.6%
Return on invested capital4.6%
Current ratio0.99
Liabilities / assets56.3%
Cash & investments€1.48B
Total debt€10.30B
Net cash (debt)-€8.82B
Free cash flow / sales9.2%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Care Delivery€3.49B 63.7%
  • Care Enablement€1.45B 26.5%
  • Value-Based Care€536.60M 9.8%

This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.

Income statement

Line item 2026 Q3
(EUR)
2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
Total Revenue as Reported €4.94B €4.86B €4.61B €19.63B €5.07B
Total Operating Revenue €4.94B €4.86B €4.61B €19.63B €5.07B
Cost of Revenue €3.66B €3.55B €3.43B €14.60B €3.68B
Gross Profit €1.28B €1.31B €1.18B €5.03B €1.39B
Operating Expense €802.32M €772.72M €803.94M €3.20B €823.23M
Selling and Admin Expenses €743.60M €736.01M €748.94M €3.03B €784.62M
-Selling & Marketing Expense €155.79M – €147.54M €618.14M €156.46M
-General & Admin Expense €587.82M – €601.40M €2.41B €628.16M
Research & Development €41.40M €39.63M €38.31M €157.98M €38.63M
Other Operating Expenses €17.32M -€2.93M €16.69M €11.40M -€19,000.00
Operating Profit €473.05M €537.27M €375.56M €1.83B €565.14M
Net Non-Operating Interest Income (Expense) -€81.46M -€82.86M -€78.68M -€314.80M -€85.40M
Non-Operating Interest Income €16.05M €14.70M €14.62M €69.61M €13.62M
Non-Operating Interest Expense €97.51M €97.55M €93.30M €384.41M €99.02M
Other Income (Expense) -€88.96M -€71.41M -€89.36M €212,000.00 €28.72M
Gain on Sale of Security -€8.71M -€10.70M -€10.12M -€120.83M -€36.88M
Earnings from Equity Interest €18.16M -€41.26M €41.32M €181.37M €41.69M
Special Income (Charges) -€98.41M -€19.46M -€120.56M -€60.32M €23.91M
-Gain on Sale Of Business -€99.86M -€16.34M -€134.99M -€61.32M €22.43M
-Gain on Sale of Property/Plant/Equipment €1.44M -€3.12M €14.43M €993,000.00 €1.49M
Pretax Profit €302.63M €383.00M €207.52M €1.51B €508.46M
Tax €77.84M €89.83M €42.75M €320.97M €106.44M
Net Profit €224.80M €293.17M €164.76M €1.19B €402.02M
Profit from Continuing Operations €224.80M €293.17M €164.76M €1.19B €402.02M
Minority Interests €65.02M €74.79M €47.23M €212.90M €74.94M
Net Income to Parent Company €159.78M €218.38M €117.53M €978.37M €327.08M
Net Income to Common Stockholders €159.78M €218.38M €117.53M €978.37M €327.08M
Basic EPS €0.31 €0.41 €0.22 €1.68 €0.57
Diluted EPS €0.31 €0.41 €0.22 €1.68 €0.57
Dividend Per Share €0.00 €0.75 €0.00 €0.72 €0.00

Balance sheet

Line item 2026 Q3
(EUR)
2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
Total Assets €31.45B €31.29B €31.47B €31.00B €31.00B
Total Current Assets €7.84B €7.69B €8.11B €7.90B €7.90B
Cash and Cash Equivalents & Short-Term Investments €1.48B €1.45B €1.62B €1.82B €1.82B
-Cash and Cash Equivalents €1.10B €1.06B €1.24B €1.58B €1.58B
-Short Term Investments €383.99M €388.10M €384.20M €238.77M €238.77M
Receivables €3.45B €3.47B €3.72B €3.66B €3.66B
-Accounts Receivable €3.31B €3.35B €3.58B €3.16B €3.16B
-Taxes Receivable €101.09M €85.45M €103.89M €290.39M €290.39M
-Due from Related Parties Current €34.69M €29.57M €29.50M €32.68M €32.68M
Inventory €2.41B €2.33B €2.30B €2.14B €2.14B
Other Current Assets €493.61M €442.88M €466.17M €211.81M €211.81M
Total Non-Current Assets €23.61B €23.60B €23.36B €23.10B €23.10B
Net PPE €6.38B €6.43B €6.44B €6.50B €6.50B
-Gross PPE €6.38B €6.43B €6.44B €17.68B €17.68B
Investments and Advances €1.37B €1.36B €1.33B €1.32B €1.32B
-Available for Sale Securities €687.91M €695.53M €628.92M €357.15M €357.15M
-Long Term Equity Investment €678.32M €660.69M €701.40M €663.65M €663.65M
Non Current Accounts Receivables €137.00M €150.02M €95.90M – –
Goodwill and Other Intangible Assets €15.27B €15.25B €15.10B €14.83B €14.83B
-Goodwill €14.02B €13.97B €13.85B €13.57B €13.57B
-Other Intangible Assets €1.26B €1.28B €1.26B €1.25B €1.25B
Non-Current Deferred Assets €301.26M €273.62M €249.49M €236.55M €236.55M
Other Non-Current Assets €145.12M €146.45M €137.49M €218.23M €218.23M
Total Liabilities €17.69B €17.76B €17.26B €16.72B €16.72B
Total Current Liabilities €7.91B €7.18B €6.73B €6.25B €6.25B
Payables €1.19B €1.12B €1.04B €1.11B €1.11B
-Accounts Payable €927.60M €891.84M €890.43M €835.55M €835.55M
-Total Tax Payable €266.21M €232.85M €151.79M €278.84M €278.84M
Short-Term Debt and Capital Lease Obligation €2.97B €2.33B €2.39B €2.20B €2.20B
-Current Debt €2.39B €1.74B €1.80B €1.61B €1.61B
-Current Capital Lease Obligation €585.18M €583.86M €593.28M €584.29M €584.29M
Current Provisions €383.20M €404.51M €367.55M €431.37M €431.37M
Other Current Liabilities €3.35B €3.32B €2.93B €1.44B €1.44B
Total Non-Current Liabilities €9.79B €10.58B €10.53B €10.47B €10.47B
Long Term Accounts Payable and Other Payables €111.67M €120.08M €112.35M €108.74M €108.74M
Long Term Debt and Capital Lease Obligation €7.91B €8.64B €8.64B €8.60B €8.60B
-Long Term Debt €5.15B €5.82B €5.74B €5.69B €5.69B
-Long Term Capital Lease Obligation €2.76B €2.81B €2.90B €2.91B €2.91B
Non-Current Liabilities €231.74M €198.45M €182.53M €173.35M €173.35M
Non-Current Deferred Liabilities €658.38M €673.10M €703.29M €699.28M €699.28M
Employee Benefits €507.22M €578.25M €574.20M €679.39M €679.39M
Other Non-Current Liabilities €365.17M €376.45M €320.40M €60.36M €60.36M
Total Equity €13.76B €13.53B €14.20B €14.28B €14.28B
Stockholders' Equity €12.79B €12.56B €13.24B €13.31B €13.31B
Capital Stock €268.56M €268.56M €293.41M €293.41M €293.41M
-Common Stock €268.56M €268.56M €293.41M €293.41M €293.41M
Additional Paid-In Capital €1.88B €1.60B €3.03B €3.08B €3.08B
Retained Earnings €12.23B €12.09B €12.30B €12.21B €12.21B
Less: Treasury Stock -€357.12M -€93.79M -€940.59M -€586.09M -€586.09M
Gains/Losses Not Affecting Retained Earnings -€1.22B -€1.31B -€1.44B -€1.68B -€1.68B
Minority Interests €964.81M €974.54M €962.89M €972.98M €972.98M
-Loans Receivable – – – €953,000.00 €953,000.00
-Notes Receivable – – – €65.42M €65.42M
-Accrued Interest Receivable – – – €21.40M €21.40M
-Other Receivables – – – €292.88M €292.88M
-Receivables Adjustments Allowances – – – -€207.68M -€207.68M
Prepaid Assets – – – €23.32M €23.32M
Restricted Cash – – – €16.60M €16.60M
-Accumulated Depreciation – – – -€11.18B -€11.18B
-Held to Maturity Securities – – – €302.68M €302.68M
-Other Payable – – – €238,000.00 €238,000.00
Current Accrued Expenses – – – €263.33M €263.33M
Current Deferred Liabilities – – – €114.37M €114.37M
Derivative Product Liabilities – – – €155.04M €155.04M

Cash flow

Line item 2026 Q3
(EUR)
2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
Operating Cash Flow €797.56M €860.30M €226.89M €2.68B €1.00B
Net cash flow from continuing operations €797.56M €860.30M €226.89M €2.68B €1.00B
Net Income from Continuing Operations €224.80M €293.17M €164.76M €1.19B €402.02M
Gain/Loss from Continuing Operations -€25.34M €37.16M -€32.55M -€58.13M -€23.77M
Depreciation & Depletion & Amortization €433.00M €363.11M €462.94M €1.50B €373.55M
Deferred Tax -€63.68M -€52.16M -€10.28M -€27.21M €3.34M
Other Non-Cash Items €81.46M €82.86M €78.68M €314.80M €85.40M
Change in Working Capital €325.15M €297.16M -€358.04M €138.24M €152.90M
-Change in Receivables €48.92M €252.63M -€382.18M -€69.06M €98.94M
-Change in Inventory -€85.05M -€17.25M -€146.78M -€248.66M -€59.17M
-Change in Payables and Accrued Expense €422.44M €118.25M €133.90M €249.06M -€74.24M
-Change in Other Current Assets -€61.16M -€56.47M €37.02M €206.90M €187.38M
Net cash flow from investing -€209.87M -€270.76M -€169.48M -€722.53M -€418.23M
Net Cash Flow from Continuing Investing Activities -€209.87M -€270.76M -€169.48M -€722.53M -€418.23M
Net PPE Purchase and Sale -€233.63M -€235.35M -€186.99M -€898.67M -€417.96M
Net Business Purchase and Sale €10.46M -€2.62M -€3.13M €180.17M €35.26M
Net Investment Purchase and Sale €13.30M -€32.79M €20.64M -€4.02M -€35.53M
Financing Cash Flow -€564.56M -€769.54M -€436.09M -€1.40B -€208.39M
Net Cash Flow from Continuing Financing Activities -€564.56M -€769.54M -€436.09M -€1.40B -€208.39M
Net Issuance Payments Of Debt -€201.66M -€147.03M -€16.30M €149.58M €285.71M
Net Common Stock Issuance -€284.18M -€144.64M -€347.33M -€585.29M -€434.17M
Cash Dividends Paid €0.00 – – -€422.52M €0.00
Net Other Financing Charges -€78.72M -€77.70M -€72.45M -€544.99M -€59.93M
Ending Cash Balance €1.10B €1.06B €1.24B €1.60B €1.60B
Net Change in Cash €23.13M -€180.00M -€378.68M €555.26M €375.07M
Beginning Cash Balance €1.06B €1.24B €1.60B €1.19B €1.26B
Effect of Exchange Rate Changes €15.11M €2.10M €18.71M -€141.48M -€32.18M
Free Cash Flow €559.59M €619.90M €36.82M €1.77B €578.67M

Discussion

No comments yet — be the first to weigh in on FMS.

Sign in to join the discussion.

Scroll to Top